Extracorporeal membrane oxygenation versus invasive ventilation in patients with COVID-19 acute respiratory distress syndrome and pneumomediastinum: A cohort trial

被引:3
作者
Attou, Rachid [1 ]
Redant, Sebastien [1 ]
Velissaris, Dimitrios [2 ]
Kefer, Keitiane [1 ]
Abou Lebdeh, Mazen [1 ]
Waterplas, Eric [1 ]
Pierrakos, Charalampos [1 ]
机构
[1] Univ Libre Bruxelles, Brugmann Univ Hosp, Dept Intens Care, B-1050 Brussels, Belgium
[2] Univ Hosp Patras, Dept Internal Med, Patras, Greece
关键词
ARDS; artificial ventilation; coronavirus disease 2019; ECMO; mechanical ventilation; mediastinal emphysema; mortality; MECHANICAL VENTILATION; FAILURE; ECMO;
D O I
10.1111/aor.14760
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Background: Patients with severe respiratory failure due to COVID-19 who are not under mechanical ventilation may develop severe hypoxemia when complicated with spontaneous pneumomediastinum (PM). These patients may be harmed by invasive ventilation. Alternatively, veno-venous (V-V) extracorporeal membrane oxygenation (ECMO) may be applied. We report on the efficacy of V-V ECMO and invasive ventilation as initial advanced respiratory support in patients with COVID-19 and acute respiratory failure due to spontaneous PM. Methods: This was a retrospective cohort study performed between March 2020 and January 2022. Enrolled patients had COVID-19 and acute respiratory failure due to spontaneous PM and were not invasively ventilated. Patients were treated in the intensive care unit (ICU) with invasive ventilation (invasive ventilation group) or V-V ECMO support (V-V ECMO group) as the main therapeutic option. The primary outcomes were mortality and ICU discharge at 90 days after ICU admission. Results: Twenty-two patients were included in this study (invasive ventilation group: 13 [59%]; V-V ECMO group: 9 [41%]). The V-V ECMO strategy was significantly associated with lower mortality (hazard ratio [HR] 0.33 [95% CI 0.12-0.97], p = 0.04). Five (38%) patients in the V-V ECMO group were intubated and eight (89%) patients in the invasive ventilation group required V-V ECMO support within 30 days from ICU admission. Three (33%) patients in the V-V ECMO group were discharged from ICU within 90 days compared to one (8%) patient in the invasive ventilation group (HR 4.71 [95% CI 0.48-45.3], p = 0.18). Conclusions: Preliminary data suggest that V-V ECMO without invasive ventilation may improve survival in COVID-19-related acute respiratory failure due to spontaneous PM. The study's retrospective design and limited sample size underscore the necessity for additional investigation and warrant caution.
引用
收藏
页码:1038 / 1048
页数:11
相关论文
共 50 条
[41]   Extracorporeal Membrane Oxygenation in Acute Respiratory Distress Syndrome: How Do We Expand Capacity in the COVID-19 Era? [J].
Peeler, Anna ;
Gleason, Kelly T. ;
Cho, Sung-Min ;
Davidson, Patricia M. .
HEART LUNG AND CIRCULATION, 2021, 30 (05) :623-625
[42]   Extracorporeal membrane oxygenation for COVID-19 and influenza H1N1 associated acute respiratory distress syndrome: a multicenter retrospective cohort study [J].
Fanelli, Vito ;
Giani, Marco ;
Grasselli, Giacomo ;
Mojoli, Francesco ;
Martucci, Gennaro ;
Grazioli, Lorenzo ;
Alessandri, Francesco ;
Mongodi, Silvia ;
Sales, Gabriele ;
Montrucchio, Giorgia ;
Pizzi, Costanza ;
Richiardi, Lorenzo ;
Lorini, Luca ;
Arcadipane, Antonio ;
Pesenti, Antonio ;
Foti, Giuseppe ;
Patroniti, Nicolo ;
Brazzi, Luca ;
Ranieri, VMarco .
CRITICAL CARE, 2022, 26 (01)
[43]   Worsening COVID-19 Acute Respiratory Distress Syndrome: Pneumomediastinum? [J].
Barbas, Carmen Silvia Valente ;
Isola, Alexandre Marini ;
Baldisserotto, Sergio .
CRITICAL CARE MEDICINE, 2023, 51 (01) :145-148
[44]   Survival Predictors in Acute Respiratory Distress Syndrome With Extracorporeal Membrane Oxygenation [J].
Chiu, Li-Chung ;
Tsai, Feng-Chun ;
Hu, Han-Chung ;
Chang, Chih-Hao ;
Hung, Chen-Yiu ;
Lee, Chung-Shu ;
Li, Shih-Hong ;
Lin, Shih-Wei ;
Li, Li-Fu ;
Huang, Chung-Chi ;
Chen, Ning-Hung ;
Yang, Cheng-Ta ;
Chen, Yung-Chang ;
Kao, Kuo-Chin .
ANNALS OF THORACIC SURGERY, 2015, 99 (01) :243-250
[45]   Efficacy and Safety of Extracorporeal Membrane Oxygenation in Patients under Mechanical Ventilation with COVID-19 and Severe Acute Respiratory Distress Syndrome: A Health Technology Assessment [J].
Toro-Huamanchumo, Carlos J. ;
Castro-Reyes, Maribel M. ;
Peralta, Veronica ;
Venancio-Huerta, Julissa E. ;
Puescas-Sanchez, Pablo R. ;
Pena-Sanchez, Eric R. .
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (10)
[46]   Use of Venovenous Extracorporeal Membrane Oxygenation in Critically-Ill Patients With COVID-19 [J].
Jozwiak, Mathieu ;
Chiche, Jean-Daniel ;
Charpentier, Julien ;
Ait Hamou, Zakaria ;
Jaubert, Paul ;
Benghanem, Sarah ;
Dupland, Pierre ;
Gavaud, Ariane ;
Pene, Frederic ;
Cariou, Alain ;
Mira, Jean-Paul ;
Nguyen, Lee S. .
FRONTIERS IN MEDICINE, 2020, 7
[47]   Adjuvant treatments to invasive mechanical ventilation in the management of acute respiratory distress syndrome secondary to COVID-19 [J].
Escribano-Santana, I. ;
Martinez-Gimeno, M. L. ;
Herraiz-Bermejo, L. .
ENFERMERIA INTENSIVA, 2023, 34 (02) :90-99
[48]   Extracorporeal Membrane Oxygenation in Immunocompromised Patients With Acute Respiratory Distress Syndrome-A Retrospective Cohort Study [J].
Cheng, Chiao-Feng ;
Chen, You-Yi ;
Shih, Ming-Chieh ;
Huang, Yi-Min ;
Tseng, Li-Jung ;
Lai, Chien-Heng ;
Lan, Ting-Yuan ;
Lu, Cheng-Hsun ;
Hsieh, Song-Chou ;
Li, Ko-Jen ;
Chi, Nai-Hsin ;
Yu, Hsi-Yu ;
Chen, Yih-Sharng ;
Wang, Chih-Hsien .
FRONTIERS IN MEDICINE, 2021, 8
[49]   Extracorporeal membrane oxygenation in adults with acute respiratory distress syndrome [J].
Hirshberg, Eliotte ;
Miller, Russell R., III ;
Morris, Alan H. .
CURRENT OPINION IN CRITICAL CARE, 2013, 19 (01) :38-43
[50]   Extracorporeal membrane oxygenation support in adult patients with acute respiratory distress syndrome [J].
Na, Soo Jin ;
Jeon, Kyeongman .
EXPERT REVIEW OF RESPIRATORY MEDICINE, 2020, 14 (05) :511-519